Patents by Inventor Blake Lee Neubauer

Blake Lee Neubauer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted benzopyrans as selective estrogen receptor-beta agonists
    Patent number: 7217734
    Abstract: The present invention relates to substituted benzopyran derivatives, stereoisomers, and pharmaceutical acceptable salts thereof and processes for the preparation of the same. The compounds of the present invention are useful as Estrogen Receptor ? agonists. Such agonists are useful for the treating Estrogen Receptor ? mediated diseases such as prostate cancer.
    Type: Grant
    Filed: November 7, 2002
    Date of Patent: May 15, 2007
    Assignee: Eli Lilly and Company
    Inventors: Jeffrey Alan Dodge, Venkatesh Krishnan, Charles Willis Lugar, III, Blake Lee Neubauer, Bryan Hurst Norman, Lance Allen Pfeifer, Timothy Ivo Richardson
  • Substituted benzopyrans as selective estrogen receptor-beta agonists
    Publication number: 20040249167
    Abstract: The present invention relates to substituted benzopyran derivatives, stereoisomers, and pharmaceutical acceptable salts thereof and processes for the preparation of the same. The compounds of the present invention are useful as Estrogen Receptor &bgr; agonists. Such agonists are useful for the treating Estrogen Receptor &bgr; mediated diseases such as prostate cancer.
    Type: Application
    Filed: April 20, 2004
    Publication date: December 9, 2004
    Inventors: Jeffrey Alan Dodge, Venkatesh Krishnan, Charles Willis Lugar, Blake Lee Neubauer, Bryan Hurst Norman, Lance Allen Pfeifer, Timothy Ivo Richardson
  • Substituted benzopyrans as selective estrogen receptor &bgr; agonists
    Patent number: 6630508
    Abstract: The present invention relates to substituted benzopyran derivatives, stereoisomers, and pharmaceutical acceptable salts thereof and processes for the preparation of the same. The compounds of the present invention are useful as Estrogen Receptor &bgr; agonists. Such agonists are useful for treating Estrogen Receptor &bgr; mediated diseases such as prostate cancer.
    Type: Grant
    Filed: January 22, 2003
    Date of Patent: October 7, 2003
    Assignee: Eli Lilly and Company
    Inventors: Jeffrey Alan Dodge, Venkatesh Krishnan, Charles Willis Lugar, III, Blake Lee Neubauer